Ingen Technologies Inc · OTC:IGNT

Ingen Technologies — Investor Presentation (February 2011)

13 slides from Ingen Technologies's investor presentation, Feb 17, 2011

  1. Slide 1: Oxyview - Ingen Technologies, Inc.

    sey (niignene Mole mS IES, INC. ~~

  2. Slide 2: Introducing Oxyview and the Smart Nasal Cannula

    Introducing Oxyview® Oxyview® is a safety device and the world's first in-line oxygen flow-meter. The Oxyview® quickly turns your nasal cannula into a Smart Nasal Cannula that is capable to monitoring your oxygen flow, while at the same time assures proper equipment function. This is a low cost solu

  3. Slide 3: Revolutionary Oxyview Flow-Meter

    Revolutionary Oxyview Flow- Meter  In-line with cannula, near patient  Works in any position (non-gravity dependent)  Patient Friendly and Durable  Lightweight  Inexpensive  More Accurate Allows clinician to see oxygen flow during rehab and at home when a patient requires extenders to be attac

  4. Slide 4: What Is Oxyview?

    What Is Oxyview ? ®  Oxyview is a flow-meter. ®  Oxyview mounts between the cannula and the tank “in-line” ®  Oxyview delivers an easily read confirmation of actual flow ®  Oxyview is the worlds first gravity independent flow-meter ®  Oxyview is pneumatic and requires no batteries ®  Oxyview c

  5. Slide 5: ISO 13485:2003 Certified, FDA Registered, DHS Licensed

     ISO 13485:2003 Certified  FDA Registered  DHS Licensed  CMS Medicare Approved Reimbursement Code  Made in the USA

  6. Slide 6: Smart Nasal Cannula features

     Adjustable over-the-ear style  Soft non-flared nasal top  One piece seamless design  Clear lightweight tubing  Crush-resistant tubing  Latex-free safe material construction  Oxyview® inline Flow-Meter  Life-Time Warranty

  7. Slide 7: Conventional Flow-Meters

    Conventional Flow- Meters  Attach at the tank, distant from patient  Only works upright (gravity)  Bulky  Heavy  Expensive  Less Accurate $43 $52 $55 $895

  8. Slide 8: Differences

    Differences Oxyview® Conventional Flow- Meters Oxyview works in any direction, hands-free, using several Conventional flow-meters work on two forces, oxygen controlled forces to include oxygen flow, cyclonic induction flow and gravity. and Ingen's patented proprietary gravity-independent spring tec

  9. Slide 9: Home Care & Assisted Living

    Home Care & Assisted Living More and more people are using oxygen therapy outside the hospital, permitting them to lead active, productive lives. People with asthma, emphysema, chronic bronchitis, occupational lung disease, lung cancer, cystic fibrosis, or congestive heart failure may use oxygen the

  10. Slide 10: Market Research Data

    Market Research Data  8-9%  of Americans suffer from respiratory conditions such as: Asthma  COPD Bronchitis   The largest respiratory market is asthma.  Oxyview applies to the non-asthma markets which represents $4Billion today  Despite and will increase to $6Billion by 2012. the delivery ap

  11. Slide 11: Market Projections

    Market Projections Overall, respiratory has had excellent growth of 17% per annum since 1997  with projected growth of 10% per year for the next few years. 8-9% US Market  11,500,000 Americans have COPD, increasing 5-6% annually  Aging population increasing for the 55+ target audience  Smoking p

  12. Slide 12: Other Markets for Oxyview

    Other Markets for Oxyview  Aviation (Commercial and Private)  Emergency Response (Ambulance and Paramedics)  Fire Department  Military and Department of Defense

  13. Slide 13: Thank You!

    Thank You! Manufactured By: TECHNOLOGI

Ingen Technologies — Investor Presentation (February 2011) on 6ix